As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Early animal studies show that a single vaccine could protect the recipient from different variants of the coronaviruses that cause COVID-19, the flu and the common cold. In addition to creating ...

Scientists at Scripps Research have developed a universal vaccine, offering protection against multiple coronaviruses, ...

Molecular docking along with other analyses revealed that caffeine binds strongly to the spike protein's active site and exhibits high binding stability. Notably, a drug appropriateness analysis ...

The universal vaccine can protect one from multiple coronaviruses, even those causing the flu and common cold, and eliminate ...

Being sugar-coated doesn’t just help the medicine go down, as the song goes, but it can also help a virus evade the immune ...